Live Breaking News & Updates on Sangamo Therapeutics Daily
Stay updated with breaking news from Sangamo therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HC Wainwright reaffirmed their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report issued on Wednesday morning, Benzinga reports. They currently have a $5.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at ($0.05) […] ....
HC Wainwright reissued their buy rating on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report released on Wednesday morning, Benzinga reports. The brokerage currently has a $5.00 price objective on the biopharmaceutical company’s stock. HC Wainwright also issued estimates for Sangamo Therapeutics’ Q1 2025 earnings at ($0.05) EPS, Q2 2025 earnings at […] ....
Sangamo Therapeutics' (SGMO) "Buy" Rating Reiterated at HC Wainwright dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Head to Head Review: Sangamo Therapeutics (NASDAQ:SGMO) versus Windtree Therapeutics (NASDAQ:WINT) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Sangamo Therapeutics (SGMO) Scheduled to Post Quarterly Earnings on Thursday theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.